Simplex Trading
WVE icon

Simplex Trading’s Wave Life Sciences WVE Stock Holding History

Simplex Trading’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$639K Sell
88,200
-100,900
-53% -$1.31M ﹤0.01% 2988
2025
Q4 		$3.21M Buy
189,100
+173,200
+1,089% +$1.76M ﹤0.01% 1600
2025
Q3 		$116K Buy
15,900
+13,200
+489% +$107K ﹤0.01% 5577
2025
Q2 		$17K Sell
2,700
-38,800
-93% -$256K ﹤0.01% 6926
2025
Q1 		$335K Buy
41,500
+5,200
+14% +$56.9K ﹤0.01% 3827
2024
Q4 		$449K Buy
36,300
+13,300
+58% +$178K ﹤0.01% 3661
2024
Q3 		$188K Buy
23,000
+14,900
+184% +$89.1K ﹤0.01% 4577
2024
Q2 		$40K Buy
8,100
+4,800
+145% +$27.4K ﹤0.01% 6316
2024
Q1 		$20K Sell
3,300
-500
-13% -$2.5K ﹤0.01% 7103
2023
Q4 		$19K Buy
3,800
+3,300
+660% +$17.6K ﹤0.01% 6976
2023
Q3 		$2K Sell
500
-600
-55% -$2.74K ﹤0.01% 8182
2023
Q2 		$4K Sell
1,100
-7,700
-88% -$31.1K ﹤0.01% 8113
2023
Q1 		$38K Buy
8,800
+4,300
+96% +$19.7K ﹤0.01% 6243
2022
Q4 		$31K Buy
4,500
+2,100
+88% +$9.68K ﹤0.01% 6440
2022
Q3 		$8K Buy
2,400
+1,700
+243% +$5.63K ﹤0.01% 8458
2022
Q2 		$2K Buy
+700
New +$1.35K ﹤0.01% 9438
2022
Q1 		– Sell
-4,700
Closed -$14K – 11523
2021
Q4 		$14K Buy
4,700
+3,500
+292% +$14.5K ﹤0.01% 8765
2021
Q3 		$8K Hold
1,200
– – ﹤0.01% 9078
2021
Q2 		$7K Buy
1,200
+710
+145% +$4.64K ﹤0.01% 9317
2021
Q1 		$274K Buy
490
+68
+16% +$653 ﹤0.01% 4264
2020
Q4 		$332K Buy
422
+82
+24% +$688 ﹤0.01% 3943
2020
Q3 		$288K Buy
340
+333
+4,757% +$3.65K ﹤0.01% 3643
2020
Q2 		$7K Sell
7
-27
-79% -$254 ﹤0.01% 6849
2020
Q1 		$31K Sell
34
-606
-95% -$5.16K ﹤0.01% 5607
2019
Q4 		$512K Buy
640
+639
+63,900% +$15.7K ﹤0.01% 2729
2019
Q3 		$2K Sell
1
-36
-97% -$825 ﹤0.01% 6967
2019
Q2 		$96K Buy
+37
New +$1.04K ﹤0.01% 4236

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Simplex Trading's WVE Position: Q1 2026 in Review

Simplex Trading increased its Wave Life Sciences (WVE) stake by 323% in Q1 2026, buying an estimated $888K and bringing the position to 89,263 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #2969.

Simplex Trading first reported a position in WVE in Q1 2019 and has held it in 24 quarters since. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Simplex Trading held 89,263 shares of Wave Life Sciences worth $647K as of Q1 2026.
  • Simplex Trading bought 68,137 Wave Life Sciences shares in Q1 2026, an estimated $888K.
  • Wave Life Sciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #2969 holding.
  • Simplex Trading first reported a position in Wave Life Sciences in Q1 2019 and has held it in 24 quarters since.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.